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METHODS: Quasi-experimental, pre-post with compar-
ison groups design using 6109 adult patients in a large,
western U.S. managed care organization with one or more
of the following conditions: arthritis, diabetes, dyslipi-
demia, GERD, or hypertension. The intervention group
consisted of members whose prescription drug coverage
converted from a 2-tier to a 3-tier beneﬁt (n = 4239).
Comparison groups included those whose beneﬁts
remained in a 2-tier (n = 592) or 3-tier (n = 1278) struc-
ture. Medication adherence rates were measured in the
pre and post periods using the medication possession
ratio. Demographic and attitudinal measures were
obtained from a mail survey during the pre period. 
Statistical analyses were based on maximum likelihood
estimates from a repeated measures model to test for dif-
ferences in medication adherence controlling for the
effects of demographic variables, health status, comorbid
diseases, pharmacy plan type, and patient satisfaction.
RESULTS: Adherence rates ranged from 90.4% to 95.5%
in the pre period. The mean adherence rate in the 
intervention group decreased from 94.7% (pre period) 
to 90.2% (post period), a decrease of 4.5%. Similar
decreases occurred in the comparison groups: from
95.5% to 91.7% (-3.8%) for 2-tier subjects, and from
92.9% to 90.4% (-2.5%) for 3-tier subjects. The
decrease in the intervention group was signiﬁcantly larger
than the decrease in the 3-tier subjects (p = 0.0003) but
not statistically different from the decrease observed in
the 2-tier subjects (p = 0.27). Adherence increased slightly
as age and number of chronic conditions increased. No
relationship was observed between medication adherence
and patient satisfaction (p = 0.35 in the pre period).
CONCLUSION: Medication adherence rates were high
in the population studied. Changes in beneﬁt design (from
2 to 3-tier drug beneﬁts) had no appreciable impact on
adherence.
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OBJECTIVES: This study measured prescription drug
utilization and payment changes when Texas Medicaid
clients in one County Service Area moved from a fee-for-
service (FFS) to either a health maintenance organization
(HMO) or primary care case management (PCCM) health
care delivery model (N = 72,172). The purpose of this
study was to assess the effect that the managed care 
programs had on the prescription drug utilization of
Medicaid clients who had a carved-out prescription 
drug beneﬁt.
METHODS: Drug utilization and payment patterns were
compared for six-month periods before and after the
managed care program implementation. Medicaid clients
in FFS, HMO, and PCCM programs in three other geo-
graphical areas across the state served as comparison
groups (N = 54,061).
RESULTS: Signiﬁcant differences (p < 0.001) across plan
designs were found in the mean changes of the following
variables between study periods for child and adult
clients: 1) prescription drug use rates; 2) generic drug 
use; 3) prescription drug payments per claim; and 4) pre-
scription drug payments per client. Furthermore, these
changes were found to be signiﬁcantly different across
plan designs for child and adult antibiotic claims, and for
child antidepressant claims. Signiﬁcant differences were
found for the following variables for child and adult anti-
histamine claims, and for child NSAID claims: 1) generic
drug use; 2) prescription drug payments per claim; and
3) prescription drug payments per client. For adult anti-
depressant and NSAID claims, signiﬁcant differences
were found in the following variables: 1) prescription
drug use rates; 2) generic drug use; and 3) prescription
drug payments per client.
CONCLUSION: This study provided evidence of a
managed care spillover effect on the prescription drug 
utilization of Medicaid managed care patients, despite the
carved-out drug beneﬁt. The results of this study should
be helpful to Medicaid administrators who make deci-
sions about managed care programs and carved-out drug
beneﬁts.
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OBJECTIVE: International comparisons of horizontal
inequity in health have recently become one of the most
pertinent issues in health economics. Japan has not been
included in these international comparisons. This paper,
focusing on Japan, rectiﬁes this and considers its dynam-
ics over six years from 1992 to 1998, which has never
been considered in this ﬁeld.
METHODS: We use the Comprehensive Survey of Living
Standards in Japan (CSLSJ) for 1992, 1995, and 1998 
so as to perform international comparison following
Doorslaer and Wagstaff et al (JHE:2000). The sample 
size for each year exceeds 60,000. First of all, we regress
outpatient utilization on age, gender, self-evaluation of
health, and/or list of symptoms and deﬁne “Needs” as the
predicted. Then, Kakuwani index between actual utiliza-
tion and “Needs” is calculated.
RESULTS: In a rigorous international comparison, we
cannot ﬁnd any horizontal inequity in health in Japan.
The point estimator is larger than Belgium and less than
Canada, which means the smallest horizontal inequity 
in OECD countries. Moreover, it gradually changes 
from pro-rich to pro-poor, though this movement is not
signiﬁcant.
